-

Antech Launches trūRapid™ FOUR: Simplifying Canine Vector-Borne Disease Screening for Veterinarians

Introducing trūRapid™ FOUR: simple, fast, and accurate screening for canine vector-borne diseases

LOVELAND, Colo.--(BUSINESS WIRE)--Antech, a global veterinary diagnostics, technology and imaging company, today announced the launch of trūRapid™ FOUR, a comprehensive in-house canine vector-borne disease (CVBD) screening test.

trūRapid™ FOUR is a lateral flow test used to detect canine antibodies to Anaplasma spp., Ehrlichia spp., and Lyme C6 (Borrelia burgdorferi), as well as heartworm (Dirofilaria immitis) antigen, using whole blood, serum, or plasma.

Jimmy Barr, DVM, DACVECC, Chief Medical Officer for Mars Petcare’s Science & Diagnostics division and Antech, said: “With its speed, proven reliability, and streamlined workflow, trūRapid™ FOUR offers busy veterinary professionals a simple alternative to current testing protocols and, importantly, provides an affordable choice without compromising quality.”

Key Features of trūRapid™ FOUR include:

  • Streamlined Workflow: Requires just a few drops of sample, minimizing the need for additional blood draws or sample centrifugation. Eliminates manual snapping; the test reaction begins automatically when the sample and buffer is directly added.
  • Proven Reliability: Excellent sensitivity and specificity when compared to reference laboratory testing. For Lyme, C6 ensures high specificity, preventing false positives caused by vaccination.
  • Broad reactivity: E. canis, E. chaffeensis, and E. ewingii; A. phagocytophilum and A. platys.
  • No refrigeration: Tests can be stored at room temperature for their entire shelf life, saving refrigerator space, simplifying inventory management, and eliminating the need to warm up the test before use.
  • Eco-Friendly Design: Generates less plastic waste with no need for additional sample handling tubes — just the cartridge and a plastic pipette.

For more information, please visit antechdiagnostics.com.

About Antech

Antech is a global veterinary diagnostics company, driven by our passion for innovation that helps veterinarians deliver better animal health outcomes. Our products and services span 90+ reference laboratories around the globe; in-house diagnostic laboratory instruments and consumables, including rapid assay diagnostic products and digital cytology services; local and cloud-based data services; practice information management software and related software and support; veterinary imaging and technology; veterinary professional education and training; and board-certified specialist support services.

Contacts

Media inquiries:
Sarah Doyle, Antech: sarah.doyle@antechdx.com
Beatrix Lohn, Kekst CNC: beatrix.lohn@kekstcnc.com

Antech


Release Versions

Contacts

Media inquiries:
Sarah Doyle, Antech: sarah.doyle@antechdx.com
Beatrix Lohn, Kekst CNC: beatrix.lohn@kekstcnc.com

More News From Antech

ANTECH™ Launches RapidRead™ Dental, the AI-Powered Radiology Interpretation Tool Revolutionizing Veterinary Dentistry

LOVELAND, Colo.--(BUSINESS WIRE)--ANTECH, a global veterinary diagnostics, technology and imaging company, today announced the launch of RapidRead Dental, an Artificial Intelligence (AI) powered radiology interpretation tool, that delivers accurate dental radiograph evaluations in approximately 10 minutes. Developed by Board-Certified Veterinary Dentists using over 55,000 images and 275,000 teeth, the tool offers comprehensive tooth-by-tooth analysis with 98% accuracy. RapidRead Dental uses ANT...

Antech™ Expands Vector-Borne Disease Portfolio with Enhanced Accuplex™ and Most Comprehensive PCR Panel to Date

LOVELAND, Colo.--(BUSINESS WIRE)--Antech™, a global veterinary diagnostics, technology and imaging company, today announced the launch of two new vector-borne disease diagnostics in their expanding portfolio: enhanced Accuplex™, a reference lab canine vector-borne disease (CVBD) screening test which now detects seven pathogens, and an enhanced vector-borne disease PCR profile, the veterinary industry’s most comprehensive PCR panel of its kind. Based on current testing data disseminated by the C...

Antech’s breakthrough cancer screening tool launches in Europe, supporting early canine cancer detection

VIERNHEIM, Germany--(BUSINESS WIRE)--Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the launch of the breakthrough in-hospital Nu.Q® Canine Cancer Test in Europe. A rapid, accurate, targeted cancer screening tool for high-risk breeds and older dogs, Nu.Q® testing also includes prevalent types of canine cancers, enabling veterinarians and pet owners to make informed decisions a...
Back to Newsroom